Gemcitabine, alone or in combination with cisplatin, in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised, phase III study

Trial Profile

Gemcitabine, alone or in combination with cisplatin, in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised, phase III study

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Apr 2016

At a glance

  • Drugs Gemcitabine (Primary) ; Cisplatin
  • Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms ABC-01; ABC-02
  • Most Recent Events

    • 26 Apr 2016 Results published in the British Journal of Cancer
    • 16 Jul 2012 Actual end date (August 2008) added as reported by ClinicalTrials.gov.
    • 08 Apr 2010 Primary endpoint results published in the New England Journal of Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top